Muscular Dystrophy Canada Rare Disease Day Update
Rare Disease Day, which occurs on the last day of February (Feb 28th, 2021), is meant to raise awareness amongst the general public and decision-makers about rare diseases and their impact on individuals’ lives. This year, Rare Disease Day will look a little different around the world as we connect virtually instead of in person due to the ongoing COVID-19 pandemic.
Considering many neuromuscular conditions are considered rare, and even ultra-rare, Muscular Dystrophy Canada (MDC) will be featuring individuals with lived experience with varying neuromuscular disorders.
In the week leading up to Rare Disease Day, each day MDC will spotlight a client and their response to the question: how has it been living with a NMD in the midst of the COVID-19 pandemic? These personal stories will showcase the diversified impact of the pandemic on the quality of lives of individuals affected by neuromuscular conditions and reveal individuals’ experiences with interrupted care, increased social isolation/fatigue, frequent cancellation or postponement of treatments and clinic visits, allied health and primary care or specialist appointments, and interrupted rehabilitation and home care supports.
The stories will also highlight the resilience of individuals and their families, the benefits of virtual tele-care and programs for those with mobility challenges and the positive lessons the pandemic has offered. In addition to the personal stories, to increase awareness and knowledge of NMDs, there will be a short plain-language descriptions of the following groups that fall within MDC’s umbrella:
(1) Muscular Dystrophies
(2) Congenital Muscular Dystrophies
(3) Congenital Myopathies
(4) Auto-immune Mediated Myopathies
(5) Metabolic Myopathies
(6) Genetic and Immune-Mediated Neuromuscular Junction Disorders
(7) Hereditary Peripheral Nerve Disorders (Genetic Neuropathies)
(8) Immune-Mediated Peripheral Nerve Disorders
(9) SMA and related Disorders
For more information about Rare Disease Day, please email
Return to the February 2021 Newsletter
Read next...
Six Annual NMD4C and MDC Clinical Fellowship Competition from Opens May 1st
Together, NMD4C and MDC are excited to open our 2027 annual funding competition to provide clinical fellowship award(s) in neuromuscular medicine and electromyography (EMG)! This annual funding competition provides one-year salary support ($80,000) for early-career clinicians to participate in Canadian neuromuscular medicine and EMG fellowship training programs.
Announcing the 2026 NMD4C Award Recipients
We are excited to announce the recipients of the 2026 NMD4C Awards, recognizing excellence, leadership, and impact across Canada’s neuromuscular research community. In this fourth cycle, the program introduces two new award categories, and expand on our ability to celebrate the work of contributions of trainees and patient partners who strengthen our national network.
Expanding Our Impact: NMD4C BSTC Launches New Subcommittees and Welcomes New Members
We are so excited to introduce the new members of the NMD4C Basic Science Trainee Committee! This enthusiastic group of researchers from across the country is stepping up to contribute to some of our most important initiatives for trainees.